John Nuss, Chief Scientific Officer at Ventyx Biosciences, Inc. (VTYX), sold 59,900 shares at $32.87 ($2.0M) on 2023-04-03, disclosed to the SEC on 2023-04-05.
Open-market sale of $2.0M VTYX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.87 | 29,900 | $983K | 49.9% |
| 2 | $32.87 | 29,900 | $983K | 49.9% |
| 3 | $33.57 | 100 | $3K | 0.2% |
| Total | $32.87 avg | 59,900 | $2.0M | 100% |
| Filing → |
| VTYX | SELL | 2024-12-30 | $50K | — | Filing → |
| VTYX | SELL | 2024-12-19 | $30K | — | Filing → |
| VTYX | SELL | 2024-04-03 | $9K | — | Filing → |